{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:06:48Z","timestamp":1791846408468,"version":"4.3.4"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Parathyroid carcinoma (PC) is a rare disease, with a frequency of 0.005% of all malignancies. Approximately 30% of patients will develop metastases at some point in the disease. Nonsecreting PC represents &lt;10% of all PC and is harder to diagnose. Here, we report the case of a patient suffering from metastatic nonsecreting PC who has been (and still is) monitored for 4.5 years with <jats:sup>18<\/jats:sup>F-fluorocholine PET\/CT.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005825","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T21:00:18Z","timestamp":1756933218000},"page":"e617-e620","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["18F-Fluorocholine PET\/CT for the Staging and Follow-up of a Patient Suffering From Metastatic Parathyroid Carcinoma"],"prefix":"10.1097","volume":"50","author":[{"given":"Margaux","family":"Brument","sequence":"first","affiliation":[{"name":"Department of Radiotherapy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Zanetta","sequence":"additional","affiliation":[{"name":"Department of Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5606-8467","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Drouet","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Centre Georges Fran\u00e7ois Leclerc, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"R1-20250903","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JOP.19.00540","article-title":"Contemporary evaluation and management of parathyroid carcinoma","volume":"17","author":"Fingeret","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"R2-20250903","doi-asserted-by":"crossref","first-page":"997009","DOI":"10.3389\/fonc.2022.997009","article-title":"Treatment and outcome of metastatic parathyroid carcinoma: a systematic review and pooled analysis of published cases","volume":"12","author":"Alberti","year":"2022","journal-title":"Front Oncol"},{"key":"R3-20250903","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.oraloncology.2018.09.009","article-title":"18F-Choline-PET in parathyroid carcinoma","volume":"86","author":"Morand","year":"2018","journal-title":"Oral Oncol"},{"key":"R4-20250903","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00259-015-3130-6","article-title":"18Fluorocholine PET\/CT in parathyroid carcinoma: a new tool for disease staging?","volume":"42","author":"Deandreis","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20250903","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/RLU.0000000000001652","article-title":"18F-Fluorocholine, 18F-FDG, and 18F-Fluoroethyl Tyrosine PET\/CT in parathyroid cancer","volume":"42","author":"Hatzl","year":"2017","journal-title":"Clin Nucl Med"},{"key":"R6-20250903","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4103\/wjnm.wjnm_67_18","article-title":"Evaluation of recurrent parathyroid carcinoma: a new imaging tool in uncommon entity","volume":"18","author":"Thanseer","year":"2019","journal-title":"World J Nucl Med"},{"key":"R7-20250903","doi-asserted-by":"crossref","first-page":"NP5","DOI":"10.1177\/0145561320977466","article-title":"An unusual case of primary hyperparathyroidism: case report of a bifocal intrathyroidal parathyroid carcinoma","volume":"102","author":"Damien","year":"2023","journal-title":"Ear Nose Throat J"},{"key":"R8-20250903","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/diagnostics14141548","article-title":"Dual-tracer positron emission tomography\/computed tomography with [18F]FDG and [18F]fluorocholine in a patient with metastatic parathyroid carcinoma","volume":"14","author":"Iacovitti","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"R9-20250903","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/cen.14088","article-title":"Minimally invasive parathyroid carcinoma \u2013 a missing entity between parathyroid adenoma and carcinoma: scintigraphic and histological features","volume":"91","author":"Singh","year":"2019","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T21:00:20Z","timestamp":1756933220000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005825","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"2024-11-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}